NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
1.150
+0.030 (2.68%)
At close: Feb 21, 2025, 4:00 PM
1.160
+0.010 (0.87%)
After-hours: Feb 21, 2025, 4:00 PM EST
NMTC Cash Flow Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Net Income | -7.19 | -12.32 | -11.86 | -10 | -9.95 | -13.64 | |
| Depreciation & Amortization | 0.25 | 0.25 | 0.2 | 0.12 | 0.08 | 0.05 | |
| Other Amortization | 0.19 | - | - | - | 0 | 1.91 | |
| Loss (Gain) From Sale of Assets | - | - | 0.03 | - | - | - | |
| Loss (Gain) From Sale of Investments | - | - | -0.05 | -0.01 | - | - | |
| Stock-Based Compensation | 1.38 | 1.34 | 1.11 | 0.95 | 1.79 | 1.84 | |
| Other Operating Activities | 0.41 | 0.67 | 0.11 | 0.21 | -0.02 | 6.85 | |
| Change in Accounts Receivable | -1.83 | -0.18 | 0.03 | 0.02 | -0.05 | - | |
| Change in Inventory | -0.32 | -0.91 | -1.02 | -0.61 | -0.1 | - | |
| Change in Accounts Payable | -0.03 | 0.07 | -0.25 | 0.52 | -0.35 | -0.27 | |
| Change in Other Net Operating Assets | 0.14 | 0.06 | -1.19 | 1.29 | -0.02 | -0.16 | |
| Operating Cash Flow | -6.99 | -11.01 | -12.89 | -7.52 | -8.6 | -3.43 | |
| Capital Expenditures | -0.11 | -0.12 | -0.38 | -0.28 | -0.07 | -0.12 | |
| Sale of Property, Plant & Equipment | - | - | 0.01 | - | - | - | |
| Investment in Securities | - | - | 3.03 | -2.97 | - | - | |
| Investing Cash Flow | -0.11 | -0.12 | 2.65 | -3.24 | -0.07 | -0.12 | |
| Short-Term Debt Issued | - | - | - | - | - | 8.36 | |
| Long-Term Debt Issued | - | - | - | - | - | 0.08 | |
| Total Debt Issued | - | - | - | - | - | 8.44 | |
| Net Debt Issued (Repaid) | - | - | - | - | - | 8.44 | |
| Issuance of Common Stock | 4.61 | 5.87 | 8.59 | 13.35 | 9.11 | 0.39 | |
| Repurchase of Common Stock | -0.08 | -0.08 | -0.12 | - | - | - | |
| Other Financing Activities | 1.02 | 1.48 | -1.07 | -1.33 | 2.42 | -1.51 | |
| Financing Cash Flow | 5.56 | 7.27 | 7.4 | 12.02 | 11.53 | 7.32 | |
| Net Cash Flow | -1.55 | -3.86 | -2.84 | 1.26 | 2.86 | 3.78 | |
| Free Cash Flow | -7.1 | -11.13 | -13.27 | -7.79 | -8.67 | -3.55 | |
| Free Cash Flow Margin | -123.52% | -322.39% | -389.45% | -367.67% | -3568.48% | -184.15% | |
| Free Cash Flow Per Share | -0.25 | -0.42 | -0.73 | -0.49 | -0.81 | -0.66 | |
| Levered Free Cash Flow | -4.76 | -6.72 | -8.86 | -4.18 | -5.07 | -4.65 | |
| Unlevered Free Cash Flow | -4.67 | -6.65 | -8.86 | -4.18 | -5.07 | -1.86 | |
| Change in Net Working Capital | 1.95 | 0.7 | 2.31 | -1.3 | 0.49 | 0.56 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.